Literature DB >> 9667757

Fibroblast growth factor receptor expression reflects cellular differentiation in human oral squamous carcinoma cell lines.

C S Drugan1, I C Paterson, S S Prime.   

Abstract

This study examined the expression of fibroblast growth factor receptor 2 (FGFR 2) splice variants, IIIb and IIIc, in normal and malignant human oral keratinocytes and in normal oral fibroblasts by RT-PCR using both exon-specific primers and primers common to both FGFR 2 isoforms. Fibroblasts expressed exclusively FGFR 2/IIIc whilst the normal and malignant keratinocytes co-expressed FGFR 2/IIIb and FGFR 2/IIIc. Well-differentiated keratinocytes expressed proportionally more FGFR 2/IIIb than IIIc whereas the poorly-differentiated cells expressed more FGFR 2/IIIc than IIIb. The normal and malignant keratinocytes, but not fibroblasts, expressed an additional amplification product, which consisted of both IIIb and IIIc of FGFR 2 joined by an extra base pair and with the intronic sequence removed. The results indicate that the expression of FGFR 2 isoforms reflects the degree of cellular differentiation in normal and malignant human oral keratinocytes and that receptor complexes of FGFR 2/IIIb and IIIc may regulate ligand-receptor interactions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9667757     DOI: 10.1093/carcin/19.6.1153

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  8 in total

Review 1.  Molecular pathways of lymphangiogenesis and lymph node metastasis in head and neck cancer.

Authors:  A D Karatzanis; E Koudounarakis; I Papadakis; G Velegrakis
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-10-21       Impact factor: 2.503

2.  Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation.

Authors:  Toshiyuki Ishiwata; Yoko Matsuda; Tetsushi Yamamoto; Eiji Uchida; Murray Korc; Zenya Naito
Journal:  Am J Pathol       Date:  2012-03-19       Impact factor: 4.307

Review 3.  Roles of FGFR in oral carcinogenesis.

Authors:  Xiaoyan Xie; Zhiyong Wang; Fangman Chen; Yao Yuan; Jiayi Wang; Rui Liu; Qianming Chen
Journal:  Cell Prolif       Date:  2016-06       Impact factor: 6.831

4.  Inhibition of fibroblasts reduced head and neck cancer growth by targeting fibroblast growth factor receptor.

Authors:  Larissa Sweeny; Zhiyong Liu; William Lancaster; Justin Hart; Yolanda E Hartman; Eben L Rosenthal
Journal:  Laryngoscope       Date:  2012-03-27       Impact factor: 3.325

5.  Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms.

Authors:  Haichuan Hu; Zofia Piotrowska; Patricia J Hare; Huidong Chen; Hillary E Mulvey; Aislinn Mayfield; Sundus Noeen; Krystina Kattermann; Max Greenberg; August Williams; Amanda K Riley; Jarad J Wilson; Ying-Qing Mao; Ruo-Pan Huang; Mandeep K Banwait; Jeffrey Ho; Giovanna S Crowther; Lida P Hariri; Rebecca S Heist; David P Kodack; Luca Pinello; Alice T Shaw; Mari Mino-Kenudson; Aaron N Hata; Lecia V Sequist; Cyril H Benes; Matthew J Niederst; Jeffrey A Engelman
Journal:  Cancer Cell       Date:  2021-10-07       Impact factor: 31.743

6.  Expression of keratinocyte growth factor and its receptor in rat tracheal cartilage: possible involvement in wound healing of the damaged cartilage.

Authors:  Takafumi Abo; Takeshi Nagayasu; Yoshitaka Hishikawa; Tsutomu Tagawa; Atsushi Nanashima; Takatomo Yamayoshi; Keitaro Matsumoto; Shucai An; Takehiko Koji
Journal:  Acta Histochem Cytochem       Date:  2010-04-26       Impact factor: 1.938

7.  Altered expression of fibroblast growth factor receptor 2 isoform IIIc: relevance to endometrioid adenocarcinoma carcinogenesis and histological differentiation.

Authors:  Wei-Xia Peng; Mitsuhiro Kudo; Takenori Fujii; Kiyoshi Teduka; Zenya Naito
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

Review 8.  2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology.

Authors:  Richard J Epstein; Li Jun Tian; Yan Fei Gu
Journal:  J Oncol       Date:  2021-04-30       Impact factor: 4.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.